Skip to main content
Clinical Trials/NCT01770470
NCT01770470
Completed
Not Applicable

A Pilot Study of Dietary Chitosan Chewing Gum in Dialysis Patients

University of Maryland, Baltimore1 site in 1 country15 target enrollmentApril 2010

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
End Stage Renal Disease
Sponsor
University of Maryland, Baltimore
Enrollment
15
Locations
1
Primary Endpoint
Serum phosphate
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

The purpose of the pilot study is to determine the impact of short-term administration of chitosan-containing chewing gum on phosphate levels in patients with elevated serum phosphate levels.

Detailed Description

The impact of using salivary phosphate binders in ESRD patients is not fully known. The purpose of the pilot study is to determine the impact of short-term administration of chitosan-containing chewing gum on phosphate levels in patients with elevated serum phosphate levels.

Registry
clinicaltrials.gov
Start Date
April 2010
End Date
January 2011
Last Updated
4 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Age 18-64 years old
  • ESRD receiving hemodialysis
  • serum phosphate \> 6.0 mg/dL

Exclusion Criteria

  • Unable to sign consent

Outcomes

Primary Outcomes

Serum phosphate

Time Frame: 6 weeks

Serum phosphate will be drawn 3 times per week over 2 weeks (during gum therapy), then once at 4 weeks and once at 6 weeks.

Secondary Outcomes

  • Salivary phosphate levels(6 weeks)

Study Sites (1)

Loading locations...

Similar Trials